Erin Olsen
Managing Director

Erin Olsen has more than 15 year of life sciences experience, including prior tenures in industry and consulting. At Syndax Pharmaceuticals, a clinical stage oncology company, Erin ran the new product planning function, with responsibility for competitive intelligence, forecasting, market research, lifecycle management and business development assessments, and early launch planning. Prior to Syndax, Erin worked at Navigant Consulting/Easton Associates for over a decade, specializing in product opportunity assessment, business development and licensing, and strategy for biopharmaceutical companies, with extensive expertise in the oncology therapeutic area. Erin serves on the External Review Board of Memorial Sloan Kettering Cancer Center’s Technology Development Fund (TDF). Erin received her MBA from Columbia Business School and MPH from the Mailman School at Columbia University. Prior to graduate school, Erin was an equity research associate at UBS and Bear Stearns as well as a consultant with the Advisory Board Company. Erin graduated from Haverford College with a BA in Economics.

(212) 257-5810